NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale

Joshua D. Lee, Edward V. Nunes, Patricia Novo MPA, Genie L. Bailey, Gregory S. Brigham, Allan J. Cohen, Marc Fishman, Walter Ling, Robert Lindblad, Dikla Shmueli-Blumberg, Don Stablein, Jeanine May, Dagmar Salazar, David Liu, John Rotrosen

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale'. Together they form a unique fingerprint.

Medicine & Life Sciences